Polycystic Ovary Syndrome and Risks for COVID-19 Infection: A Comprehensive Review

February 2022 in “ Reviews in Endocrine and Metabolic Disorders ”

Sebastião Freitas de Medeiros, Márcia Marly Winck Yamamoto, Matheus Antônio Souto de Medeiros, Ana Karine Lin Winck Yamamoto, Bruna Barcelo Barbosa

polycystic ovary syndrome PCOS hyperandrogenism insulin resistance chronic inflammation obesity

TLDR Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

The review examined the link between polycystic ovary syndrome (PCOS) and increased risks for COVID-19 infection, finding that women with PCOS were at a 28%-50% higher risk of contracting COVID-19 and experiencing severe outcomes. This heightened risk was attributed to common PCOS comorbidities such as obesity, insulin resistance, hyperandrogenism, and chronic inflammation, which could exacerbate COVID-19 severity. A UK study of over 21,000 PCOS patients supported these findings. The review suggested that hyperandrogenism might facilitate viral entry, while obesity and insulin resistance contributed to immune dysfunction. It emphasized the need for careful management of these comorbidities and specific care protocols for PCOS patients to mitigate COVID-19 risks.

View this study on link.springer.com →

Discuss this study in the Community →

Research cited in this study

17 / 17 results

research The Immune System Response in COVID-19 Infection in Polycystic Ovary Syndrome

1 citations , May 2021 in “International Journal Of Medical Science And Clinical Invention”

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

research The Double-Edged Sword of Testosterone’s Role in the COVID-19 Pandemic

29 citations , March 2021 in “Frontiers in Endocrinology”

Testosterone may influence COVID-19 severity and outcomes.

research Sex Differences in COVID-19: The Role of Androgens in Disease Severity and Progression

121 citations , November 2020 in “Endocrine”

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

research Clinical Symptoms of Hyperandrogenic Women Diagnosed with COVID-19

29 citations , October 2020 in “Journal of the European Academy of Dermatology and Venereology”

Women with high androgen levels may have more severe COVID-19 symptoms.

research Polycystic Ovary Syndrome (PCOS) and COVID-19: An Overlooked Female Patient Population at Potentially Higher Risk During the COVID-19 Pandemic

112 citations , July 2020 in “BMC Medicine”

Women with PCOS may be at higher risk for severe COVID-19.

research Are Sex Discordant Outcomes in COVID-19 Related to Sex Hormones?

42 citations , June 2020 in “Seminars in Oncology”

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

research Androgen Sensitivity Gateway to COVID-19 Disease Severity

123 citations , May 2020 in “Drug Development Research”

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

research Coronavirus and Obesity: Could Insulin Resistance Mediate the Severity of COVID-19 Infection?

49 citations , May 2020 in “Frontiers in Public Health”

Insulin resistance linked to obesity may increase COVID-19 severity.

A Preliminary Observation: Male Pattern Hair Loss Among Hospitalized COVID-19 Patients in Spain – A Potential Clue to the Role of Androgens in COVID-19 Severity

research A Preliminary Observation: Male Pattern Hair Loss Among Hospitalized COVID-19 Patients in Spain – A Potential Clue to the Role of Androgens in COVID-19 Severity

134 citations , April 2020 in “Journal of Cosmetic Dermatology”

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

research What Does Androgenetic Alopecia Have to Do with COVID-19? An Insight into a Potential New Therapy

47 citations , April 2020 in “Dermatologic Therapy”

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Polycystic Ovary Syndrome, Androgen Excess, and the Risk of Nonalcoholic Fatty Liver Disease in Women: A Longitudinal Study Based on a United Kingdom Primary Care Database

research Polycystic Ovary Syndrome, Androgen Excess, and the Risk of Nonalcoholic Fatty Liver Disease in Women: A Longitudinal Study Based on a United Kingdom Primary Care Database

114 citations , March 2018 in “PLOS Medicine”

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

research Vitamin D Receptor Polymorphisms and Polycystic Ovary Syndrome: A Systematic Review

36 citations , January 2017 in “Journal of Obstetrics and Gynaecology Research”

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

research Ovarian Hypertension: Polycystic Ovary Syndrome

60 citations , May 2011 in “Endocrinology and Metabolism Clinics of North America”

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

research Polycystic Ovary Syndrome: Comprehensive Overview and Diagnostic Criteria

989 citations , August 2007 in “The Lancet”

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

research Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

1744 citations , August 2006 in “The Journal of Clinical Endocrinology and Metabolism”

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

research Androgen Excess in Women: Experience with Over 1000 Consecutive Patients

947 citations , February 2004 in “The Journal of Clinical Endocrinology and Metabolism”

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

research The Pathophysiology of Polycystic Ovary Syndrome

249 citations , November 2003 in “Clinical endocrinology”

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.